Open AccessComparison of Survival Outcomes Between Patients With Malignant Mixed Mullerian Tumors and High-Grade Endometrioid, Clear Cell, and Papillary Serous Endometrial Cancers
Author(s) -
Ashley S. Felix,
Roslyn A. Stone,
Robert Bowser,
Mamatha Chivukula,
Robert P. Edwards,
Joel L. Weissfeld,
Faina Linkov
Publication year - 2011
Publication title -
international journal of gynecological cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.901
H-Index - 87
eISSN - 1525-1438
pISSN - 1048-891X
DOI - 10.1097/igc.0b013e31821a62dd
Subject(s) - medicine , serous fluid , proportional hazards model , hazard ratio , endometrial cancer , clear cell , stage (stratigraphy) , oncology , survival analysis , cohort , retrospective cohort study , overall survival , cancer , gastroenterology , carcinoma , confidence interval , paleontology , biology
Malignant mixed mullerian tumors (MMMTs) are an aggressive subtype of endometrial cancer (EC). Previous studies compare survival between high-grade endometrioid (EM), clear cell (CC), and papillary serous (PS) ECs; yet few studies compare MMMTs to these aggressive subtypes. The goal of this study was to compare recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) among EC subtypes.